TWiV 780: COVID-19 clinical update #71 with Dr. Daniel Griffin

In COVID-19 clinical update #71, Daniel Griffin reviews updated school and child care guidance from CDC, transmission in schools, accuracy of lateral flow assays, update to J&J/Janssen vaccine EUA to include GBS, interim immunogenicity of Ad.26.CoV2.s, effectiveness of mRNA vaccines to prevent hospitalization, Bamlanivimab plus Etesevimab for mild or moderate disease, and a meta-analysis of ivermectin results. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode School and child care guidance (CDC) Transmission in schools (CDC) Accuracy of lateral flow diagnostics (Lancet) GBS with Ad.26.CoV2.s vaccine (FDA) Ad.26.CoV2.s interim immunogenicity (NEJM) mRNA vaccine effectiveness to prevent hospitalization (medRxiv) Bamlanivimab plus Etesevimab (NEJM) Meta-analysis of ivermectin studies (Clin Inf Dis) Letters read on TWiV 780 Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]